Tobradex
Tobradex

7.82
Resolves localized ocular inflammation for Eye Care by combining a bactericidal antibiotic with a corticosteroid to clear infections and support surface tissue recovery.


Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Tobramycin, Dexamethasone
Reference Brand
Tobradex
Product Origin
Generic Alternative
Reference Manufacturer
Novartis
Product Form
Eye Drops
Regulatory Classification
Rx
Primary Category
Eye Care
Product Category
Corticosteroid, Aminoglycoside Antibiotic
Pharmacological Class
Ophthalmologicals
Clinical Indications
Eye inflammation, Bacterial eye infections
Manufacturer Description
Tobradex is developed to alleviate eye inflammation accompanied by bacterial infection. It is designed to target localized irritation and bacterial presence in the eye.
Mechanism of Action
Tobramycin interferes with bacterial protein synthesis, while Dexamethasone provides anti-inflammatory and immunosuppressive effects to reduce tissue swelling and redness in the eye.
Route of Administration
Topical (Ophthalmic)
Onset Time
Within minutes
Duration
4–6 hours
Contraindications
Viral or fungal eye diseases
Severe Adverse Events
Increased intraocular pressure, Cataract formation
Common Side Effects
Eye redness, Eye irritation
Uncommon Side Effects
Blurred vision
Pregnancy Safety Warnings
Consult an ophthalmologist if pregnant.
Age Restrictions
Not recommended for general pediatric use without specialist advice.
Storage Guidelines
Store below 25°C. Keep bottle tightly closed.
Related Products
Ofloxacin, Prednisolone

Tobradex FAQ

How do digital health platforms facilitate evaluation and access to Tobradex in Singapore?

Digital health directories in Singapore facilitate secure connections between individuals and qualified practitioners, who then perform clinical evaluations to verify the necessity of Tobradex, ensuring compliance with local medical access standards.

Why are there cost variations between multi-source generic Tobradex formulations and originator brands, focusing on formulation economics?

Cost differences arise from the production economics of manufacturing generic analogs, which utilize established chemical processes, compared to the research and development investment costs embedded in the originator brand pricing structure.

How can patients in Singapore verify the regulatory compliance and sourcing standards of digital health directories providing Tobramycin and Dexamethasone?

Verification involves ensuring that the provider operates in alignment with Health Sciences Authority guidelines and maintains verifiable supply chains that meet international standards for the distribution of medical substances.

What are the logistical or regulatory considerations when utilizing cross-border facilitation or importing Tobradex into Singapore for personal use?

Importing medical supplies into Singapore requires strict adherence to HSA personal import schemes, which often mandate clinical verification and compliance documentation to ensure that the imported product aligns with specific safety and standards protocols.

How does the clinical bioequivalence of Tobradex compare to other Tobramycin-Dexamethasone generic formulations?

Tobradex functions as a bioequivalent generic formulation, meaning it is designed to meet the same therapeutic performance standards and quality metrics as other bioequivalent variations of this therapeutic combination.

Identifying Tobramycin and Dexamethasone

Combining an aminoglycoside antibiotic with a potent corticosteroid, the chemical composition of Tobramycin and Dexamethasone addresses specific inflammatory conditions within the field of Eye Care. Ocular health protocols often utilize these agents to manage bacterial infections while simultaneously reducing the localized inflammatory response. Integration of these components ensures a multi-faceted approach to sustaining visual comfort.

Formulation of these agents targets the delicate tissues of the eye, requiring careful application according to the specific needs of the patient. Medical guidelines dictate their use primarily for short-term support where bacterial susceptibility exists alongside inflammation. Professionals select these agents for patients when the localized immune response requires modulation alongside standard antimicrobial therapy.

Regulatory & Classification Profile

Regulatory frameworks throughout Singapore classify formulations containing Tobramycin and Dexamethasone as Prescription-Only Medicines. Access to these therapeutic agents necessitates a validation process through a recognized medical environment. Compliance with Health Sciences Authority (HSA) guidelines prevents inappropriate distribution within public or private sectors. Obtaining these treatments requires evidence of clinical need through direct interaction with a monitor or practitioner.

Formulations & Associated Medications

Tobradex serves as a bioequivalent generic formulation containing the active ingredients Tobramycin and Dexamethasone. These components work in synergy to provide localized support for ocular health. Available formulations accessible through our website include Tobradex bottle in strengths of 0.1/0.3%. Maintaining high standards for formulation quality ensures that these therapeutic agents consistently deliver the intended chemical profile to the user.

Therapeutic Applications

  • Bacterial conjunctivitis involving inflammatory components.
  • Post-operative inflammatory conditions occurring after eye procedures.
  • Chronic ocular conditions requiring management of recurrent inflammation.
  • Blepharitis accompanied by secondary bacterial presence.
  • Episcleritis and other surface-level ocular tissue sensitivities.

Biological Action

Tobramycin targets the cellular integrity of bacterial invaders, preventing the synthesis of essential proteins required for their survival. Dexamethasone interrupts the chemical signals that trigger swelling, redness, and discomfort within the ocular tissue. Balanced, these two actions work independently to support the natural healing trajectory of the eye. Sustained usage aims to shift the ocular environment toward a stable, non-inflamed state without overloading systemic pathways.

Treatment Landscape & Drug Class

Ocular medicine categorizes the Tobramycin and Dexamethasone combination within the ophthalmic anti-infective and corticosteroid group. Compounds in this class represent foundational tools for managing sterile and non-sterile inflammatory states in specialized clinics. Modern protocols rely on such combinations to provide concentrated relief, minimizing the reach of the treatment to localized areas rather than the broader internal systems.

Understanding the Safety Profile

Physiological processing of these agents involves the localized absorption into eye tissue with minimal systemic exposure when applied accurately. Hepatic pathways may process negligible amounts of the steroid component if excessive absorption occurs, though the local nature of the application remains the primary focus. Standard biological monitoring tracks ocular pressure and surface health to ensure the tissue responds positively to the treatment. Refer to the clinical data tables provided for specific contraindications, interactions, and potential reactions.

Clinical Disclosure

Clinical overviews regarding Tobramycin and Dexamethasone provide foundational insights for individuals seeking information on ocular health management. Medications like Tobradex differ in strength based on formulation and specific medical requirements. No liability is assumed for the outcome of therapeutic decisions made without the guidance of a practitioner. Please review all labeling information and consult a healthcare professional to facilitate an evaluation of clinical suitability and safety before beginning any medical regimen.

Clinical Glossary

Aminoglycoside
A class of antibacterial compounds designed to interrupt protein synthesis within bacterial microorganisms.
Corticosteroid
A chemical agent that modulates the immune response to reduce localized swelling and irritation.
Bioequivalent
A regulatory designation indicating that a generic formulation delivers the active substance at the same rate and extent as the originator.
Ocular
Pertaining specifically to the eyes or the complex tissues comprising the visual system.
Information associated with Tobradex is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
Categories